Profile
Seiichi Yuza was the President & Representative Director of tella, Inc. from 2018 to 2019.
Prior to that, he was a Director at Titan, Inc. (Japan) and Allgene, Inc. Yuza holds a doctorate degree from the University of Tokyo, which he received in 1999.
Former positions of Seiichi Yuza
| Companies | Position | End |
|---|---|---|
| Allgene, Inc. | Director/Board Member | - |
Titan, Inc. (Japan)
 Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
| TELLA, INC. | President | 01/03/2019 |
Training of Seiichi Yuza
| University of Tokyo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Titan, Inc. (Japan)
Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Technology Services |
| Allgene, Inc. | |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Seiichi Yuza
